Menu
GeneBe

CRMP1

collapsin response mediator protein 1, the group of M38 metallopeptidases

Basic information

Region (hg38): 4:5748083-5893086

Links

ENSG00000072832NCBI:1400OMIM:602462HGNC:2365Uniprot:Q14194AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CRMP1 gene.

  • Inborn genetic diseases (28 variants)
  • not provided (13 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRMP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
6
clinvar
9
missense
28
clinvar
1
clinvar
29
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
0
Total 0 0 29 3 7

Variants in CRMP1

This is a list of pathogenic ClinVar variants found in the CRMP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-5748087-C-T Benign (Jun 25, 2018)1266411
4-5748087-C-CCTTTG Likely benign (Jan 20, 2019)1186208
4-5748087-C-CGTTTG Benign (Jun 17, 2020)1231697
4-5748133-G-A Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Jun 02, 2023)2927373
4-5748133-G-T Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Nov 09, 2023)2929631
4-5748134-T-C Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Dec 02, 2023)2179068
4-5748136-C-G Ellis-van Creveld syndrome;Curry-Hall syndrome Benign (Feb 01, 2024)1653442
4-5748139-A-C Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Nov 24, 2023)1598295
4-5748139-A-G Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Dec 30, 2023)1135171
4-5748142-T-C Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Jul 02, 2021)1670363
4-5748148-A-G Ellis-van Creveld syndrome;Curry-Hall syndrome Uncertain significance (Nov 08, 2021)1475001
4-5748153-A-G not specified • Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Apr 07, 2023)389469
4-5748165-A-G Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Jul 06, 2021)1626807
4-5748166-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome Pathogenic (Jan 30, 2024)2954304
4-5748177-T-C not specified • Ellis-van Creveld syndrome • Ellis-van Creveld syndrome;Curry-Hall syndrome • Curry-Hall syndrome Benign (Feb 01, 2024)262786
4-5748181-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome Pathogenic (Nov 04, 2019)968311
4-5748190-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome • Ellis-van Creveld syndrome Conflicting classifications of pathogenicity (Jan 31, 2024)349170
4-5748191-TTG-T Curry-Hall syndrome;Ellis-van Creveld syndrome Pathogenic (Jan 16, 2024)2922237
4-5748193-G-GATCTT Ellis-van Creveld syndrome Likely pathogenic (Jan 25, 2022)1724099
4-5748195-G-A Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Sep 19, 2022)1999521
4-5748198-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Jun 09, 2023)1118405
4-5748207-G-A Curry-Hall syndrome;Ellis-van Creveld syndrome Likely benign (Nov 24, 2023)1554377
4-5748207-G-GAACATTC Ellis-van Creveld syndrome Likely pathogenic (Feb 25, 2022)1724683
4-5748213-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Aug 29, 2023)1651202
4-5748216-C-T Ellis-van Creveld syndrome;Curry-Hall syndrome Likely benign (Apr 22, 2023)2940529

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CRMP1protein_codingprotein_codingENST00000324989 14144975
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9920.00827125742051257470.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.412443760.6500.00002314430
Missense in Polyphen81165.070.490691676
Synonymous-0.8151741611.080.00001171388
Loss of Function4.34327.60.1090.00000126350

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006200.0000615
Ashkenazi Jewish0.00009960.0000992
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration. May participate in cytokinesis. {ECO:0000269|PubMed:11562390, ECO:0000269|PubMed:19799413}.;
Pathway
Developmental Biology;Semaphorin interactions;Axon guidance;CRMPs in Sema3A signaling (Consensus)

Recessive Scores

pRec
0.163

Intolerance Scores

loftool
0.0145
rvis_EVS
-0.75
rvis_percentile_EVS
13.67

Haploinsufficiency Scores

pHI
0.533
hipred
Y
hipred_score
0.851
ghis
0.596

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.178

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Crmp1
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;

Gene ontology

Biological process
microtubule cytoskeleton organization;nucleobase-containing compound metabolic process;nervous system development;axon guidance;negative regulation of neuron projection development;negative regulation of actin filament binding
Cellular component
nucleus;centrosome;spindle;cytosol;midbody
Molecular function
protein binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;filamin binding